Food–Medication Interaction Detector (CYP450)
Flags interactions between foods/nutrients and antidiabetics, statins, anticoagulants, and antihypertensives.
Choose a diet plan, ebook, or workout plan to continue shopping.
| Parameter | Value | Parameter | Value |
|---|---|---|---|
|
Dosage
|
160 mg + 25 mg |
Strength
|
160 mg + 25 mg |
|
Pack Size
|
05909991062910 ¦ Rp ¦ 23273 28 tabl. 05909991062927 ¦ Rp ¦ 24385 14 tabl. |
Form
|
Tabletki powlekane |
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Rejestry E-zdrowia
Ludzki
doustna
10629
Bezterminowe
Novartis Farma S.p.A. Novartis Farmaceutica S.A. Novartis Farma-Productos Famaceuticos S.A. Novartis (Hellas) S.A.C.I. Novartis Hungaria Kft. Novartis Pharma B.V. Novartis Pharma GmbH Novartis Pharma S.A.S Novartis s.r.o. Novartis Sverige AG
Włochy Hiszpania Portugalia Grecja Węgry Kolumbia Niemcy Francja Czechy Szwecja
art. 16 ust. 3
Search for medications, check dosage, side effects and contraindications.
Explore dedicated Diets Premium ecosystem applications matched to this topic or cycle through more clinical tools.
Flags interactions between foods/nutrients and antidiabetics, statins, anticoagulants, and antihypertensives.
Detects absorption blockers between supplements, drugs, and morning coffee, aligning them with blood tests into a daily schedule.
Models blood glucose and insulin responses for any recipe, food, or diet day, factoring in fiber and lipid buffering.
Native Model Context Protocol server exposing Diets Premium catalogs and clinical calculators directly to external applications and integrations.